IMO, what is happening to the price is exactly what people are saying on this board. People had a chance to see the test data and are coming to realize that the pharma applications either aren't feasible at all or aren't nearly as close to being a reality as original thought.
The first round of testing was on caffeine only. Caffeine showed around 7% delivery with FUSE's tech. Then they took the testing to multiple compounds for the 2nd round. I'm sure they were hoping the other compounds would be close to caffeine's delivery, but instead, the highest they got with any of the other compounds was 1.5%. This is around 20%. How could this not be looked at as dissapointing??
I'm bummed guys. In my opinion, the data yesterday shows that we are an energy supplement company in a field of numerous others. Our hopes now are that Tiger, DJ, Cheban, et al can make us stand out and get some of the market share of 5-hour and others.